Mark Burgert

1.0k total citations
11 papers, 445 citations indexed

About

Mark Burgert is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mark Burgert has authored 11 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Mark Burgert's work include Protease and Inhibitor Mechanisms (2 papers), Cardiac Arrest and Resuscitation (2 papers) and Respiratory Support and Mechanisms (2 papers). Mark Burgert is often cited by papers focused on Protease and Inhibitor Mechanisms (2 papers), Cardiac Arrest and Resuscitation (2 papers) and Respiratory Support and Mechanisms (2 papers). Mark Burgert collaborates with scholars based in United States, United Kingdom and Australia. Mark Burgert's co-authors include Emile R. Mohler, Colin H. Macphee, Damir Hamamdzic, Robert S. Fenning, Robert L. Wilensky, Bryan E. Hoffman, Ping Zhang, Jisheng Yang, James G. Bollinger and Rosanna C. Mirabile and has published in prestigious journals such as Nature Medicine, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Mark Burgert

11 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Burgert United States	6	168	152	101	88	78	11	445
Motoko Kanzaki Japan	11	237 1.4×	129 0.8×	160 1.6×	148 1.7×	199 2.6×	17	692
Sara Oppi Italy	8	111 0.7×	84 0.6×	59 0.6×	106 1.2×	68 0.9×	15	371
Qiu-Yue Han China	15	220 1.3×	69 0.5×	85 0.8×	159 1.8×	71 0.9×	35	582
Raj Patel United States	5	140 0.8×	166 1.1×	58 0.6×	185 2.1×	97 1.2×	20	521
Xiaoju Li China	15	240 1.4×	136 0.9×	50 0.5×	45 0.5×	96 1.2×	46	546
Vicenta Llorente‐Cortés Spain	10	154 0.9×	176 1.2×	181 1.8×	136 1.5×	61 0.8×	22	472
Jian Cao China	12	167 1.0×	85 0.6×	74 0.7×	47 0.5×	34 0.4×	34	464
Antoine Rimbert France	12	114 0.7×	212 1.4×	54 0.5×	42 0.5×	76 1.0×	43	457
Véronique Caron Canada	8	202 1.2×	65 0.4×	50 0.5×	53 0.6×	68 0.9×	12	371
Ritsu Tamura Japan	13	221 1.3×	147 1.0×	57 0.6×	115 1.3×	99 1.3×	17	549

Countries citing papers authored by Mark Burgert

Since Specialization

Citations

This map shows the geographic impact of Mark Burgert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Burgert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Burgert more than expected).

Fields of papers citing papers by Mark Burgert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Burgert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Burgert. The network helps show where Mark Burgert may publish in the future.

Co-authorship network of co-authors of Mark Burgert

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Burgert. A scholar is included among the top collaborators of Mark Burgert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Burgert. Mark Burgert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Vermillion, Meghan S., M. A. Bray, Karin Rudolph, et al.. (2024). Effect of TRPV4 Antagonist GSK2798745 on Chlorine Gas-Induced Acute Lung Injury in a Swine Model. International Journal of Molecular Sciences. 25(7). 3949–3949. 3 indexed citations

Bihari, Shailesh, Melissa H. Costell, David J. Behm, et al.. (2023). Evaluation of GSK2789917-induced TRPV4 inhibition in animal models of fluid induced lung injury. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(5). 3461–3475. 2 indexed citations

Köhler, Stefan, et al.. (2021). The Costs of Creatinine Testing in the Context of a HIV Pre-Exposure Prophylaxis Demonstration Project in Eswatini. AIDS and Behavior. 26(3). 728–738. 3 indexed citations

Xie, Qing, Xin Zeng, Wensheng Xie, et al.. (2019). Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel disease. PLoS ONE. 14(4). e0215033–e0215033. 25 indexed citations

Achanta, Satyanarayana, Michael A. Gentile, Ana I. Caceres, et al.. (2019). TRPV4 Inhibitor Improves Pulmonary Function and Oxygen Saturation in a Pig Translational Model of Chlorine Gas-Induced Acute Lung Injury. A1017–A1017. 2 indexed citations

Fenning, Robert S., Mark Burgert, Damir Hamamdzic, et al.. (2015). Atherosclerotic Plaque Inflammation Varies Between Vascular Sites and Correlates With Response to Inhibition of Lipoprotein‐Associated Phospholipase A ₂. Journal of the American Heart Association. 4(2). 18 indexed citations

Richards, Daniel A., et al.. (2013). Examining the relationship between exercise tolerance and isoproterenol-based cardiac reserve in murine models of heart failure. Journal of Applied Physiology. 114(9). 1202–1210. 12 indexed citations

Alsaid, Hasan, Weike Bao, David J. Figueroa, et al.. (2011). Serial MRI characterization of the functional and morphological changes in mouse lung in response to cardiac remodeling following myocardial infarction. Magnetic Resonance in Medicine. 67(1). 191–200. 5 indexed citations

Curtis, Annie M., Lifeng Zhang, Ming Gui, et al.. (2010). Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic population. Cytometry Part B Clinical Cytometry. 78B(5). 329–337. 23 indexed citations

10.

Wilensky, Robert L., Yi Shi, Emile R. Mohler, et al.. (2008). Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nature Medicine. 14(10). 1059–1066. 294 indexed citations

11.

Laping, Nicholas J., Jeffrey I. Everitt, Kendall S. Frazier, et al.. (2007). Tumor-Specific Efficacy of Transforming Growth Factor-βRI Inhibition in Eker Rats. Clinical Cancer Research. 13(10). 3087–3099. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact